Appraisal 126

 

NICE (Single) Technology Appraisal Guidance 126: Ritixumab for the treatment of rheumatoid arthritis

View SMC's advice here

This guidance has been updated and replaced by TA195 Drugs for treatment of rheumatoid arthritis after failure of a TNF inhibitor

Published Date: 22 August 2007

Evidence

Reviewed for Scotland

This advice has been reviewed under our procedure for processing NICE appraisals to ensure it is relevant for the Scottish healthcare landscape.

Read our process for reviewing NICE guidance